FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?

FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?

A fibroblast activation protein (FAP) is an atypical type II transmembrane serine protease with both endopeptidase and post-proline dipeptidyl peptidase activity. FAP is overexpressed in cancer-associated fibroblasts (CAFs), which are found in most epithelial tumors. CAFs have been implicated in pro...

Full description

Bibliographic Details
Main Authors:	Katharina Dendl, Stefan A. Koerber, Clemens Kratochwil, Jens Cardinale, Rebecca Finck, Mardjan Dabir, Emil Novruzov, Tadashi Watabe, Vasko Kramer, Peter L. Choyke, Uwe Haberkorn, Frederik L. Giesel
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Cancers
Subjects:	FAPI-PET/CT FAP CAFs various malignancies benign diseases fibroblast
Online Access:	https://www.mdpi.com/2072-6694/13/19/4946

Similar Items

Subclass Analysis of Malignant, Inflammatory and Degenerative Pathologies Based on Multiple Timepoint FAPI-PET Acquisitions Using FAPI-02, FAPI-46 and FAPI-74
by: Frederik M. Glatting, et al.
Published: (2022-10-01)

Fully-automated production of [68Ga]Ga-FAPI-46 for clinical application
by: Sarah Spreckelmeyer, et al.
Published: (2020-12-01)

FAPI PET/CT Imaging—An Updated Review
by: Kunal Ramesh Chandekar, et al.
Published: (2023-06-01)

68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
by: Hao Wang, et al.
Published: (2021-06-01)

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer—Clinical Results with [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPi
by: Lukas Greifenstein, et al.
Published: (2022-08-01)

Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [<sup>18</sup>F]FAPI-74 with [<sup>18</sup>F]FDG in Patients with PDAC: A Prospective Exploratory Study
by: Emil Novruzov, et al.
Published: (2023-05-01)

Performance and Prospects of [<sup>68</sup>Ga]Ga-FAPI PET/CT Scans in Lung Cancer
by: Paula E. Borgonje, et al.
Published: (2022-11-01)

Radioligands Targeting Fibroblast Activation Protein (FAP)
by: Thomas Lindner, et al.
Published: (2021-11-01)

Synthesis and Evaluation of <sup>68</sup>Ga-Labeled (2<i>S</i>,4<i>S</i>)-4-Fluoropyrrolidine-2-Carbonitrile and (4<i>R</i>)-Thiazolidine-4-Carbonitrile Derivatives as Novel Fibroblast Activation Protein-Targeted PET Tracers for Cancer Imaging
by: Shreya Bendre, et al.
Published: (2023-04-01)

New Fully Automated Preparation of High Apparent Molar Activity <sup>68</sup>Ga-FAPI-46 on a Trasis AiO Platform
by: Chiara Da Pieve, et al.
Published: (2022-01-01)

Synthesis, radiolabeling, and evaluation of a (4-quinolinoyl)glycyl-2-cyanopyrrolidine analogue for fibroblast activation protein (FAP) PET imaging
by: Ni Zhang, et al.
Published: (2023-03-01)

SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis
by: Xiu Luo, et al.
Published: (2023-03-01)

circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis
by: Yan Zhao, et al.
Published: (2024-03-01)

FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma
by: Lehel Peterfi, et al.
Published: (2023-01-01)

The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies
by: Yanzhao Dong, et al.
Published: (2023-02-01)

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy
by: Sofia Koustoulidou, et al.
Published: (2021-03-01)

Radiosynthesis and First Preclinical Evaluation of the Novel 11C-Labeled FAP Inhibitor 11C-FAPI: A Comparative Study of 11C-FAPIs and (68Ga) Ga-DOTA-FAPI-04 in a High–FAP-Expression Mouse Model
by: Cheng Wang, et al.
Published: (2022-08-01)

Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer
by: Jakob Liermann, et al.
Published: (2021-02-01)

FAP-targeted PET imaging in gastrointestinal malignancies: a comprehensive review
by: Ayça Arçay Öztürk, et al.
Published: (2023-08-01)

Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
by: Junhao Wu, et al.
Published: (2022-07-01)

Research Progress of Radionuclide-Labeled Small Molecule FAP Inhibitors in Tumor Diagnosis and Treatment
by: LIU Jingru;RUI Jiangzhong;ZHU Hong
Published: (2022-04-01)

Design, Synthesis and Preclinical Assessment of <sup>99m</sup>Tc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging
by: Diana Trujillo-Benítez, et al.
Published: (2022-01-01)

Applications of FAPI PET/CT in the diagnosis and treatment of breast and the most common gynecologic malignancies: a literature review
by: Tengfei Li, et al.
Published: (2024-03-01)

Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases
by: Yan Cui, et al.
Published: (2023-09-01)

First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [<sup>177</sup>Lu]Lu-DOTA.SA.FAPi and [<sup>177</sup>Lu]Lu-DOTAGA.(SA.FAPi)<sub>2</sub>
by: Sanjana Ballal, et al.
Published: (2021-11-01)

High expressions of CD10, FAP and GPR77 in CAFs are associated with chemoresistance and worse prognosis in gastric cancer
by: Yilin Tong, et al.
Published: (2022-10-01)

Localization of Pyelonephritis by 68Ga-FAPI PET CT
by: Rajlaxmi Jagtap, et al.
Published: (2023-01-01)

Synthesis and Preclinical Evaluation of Novel <sup>68</sup>Ga-Labeled (<i>R</i>)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging
by: Shreya Bendre, et al.
Published: (2023-05-01)

Dataset of voxelwise correlated signal values of ADC, rCBV and FAP-specific PET of 13 Glioblastoma patients
by: Manuel Röhrich, et al.
Published: (2020-08-01)

Correlation between [<sup>68</sup>Ga]Ga-FAPI-46 PET Imaging and HIF-1α Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept
by: Kgomotso M. G. Mokoala, et al.
Published: (2023-08-01)

Emerging Role of FAPI PET Imaging for the Assessment of Benign Bone and Joint Diseases
by: Francesco Dondi, et al.
Published: (2022-08-01)

Automated Radiosynthesis and Micro PET/CT Imaging of 18F-FAPI-42
by: WANG Hua;WANG Meng;HUANG Shun;SUN Penghui;HU Kongzheng;XIANG Xianhong;LIN Weiyuan;ZHI Shengfang;TANG Ganghua;HAN Yanjiang
Published: (2023-08-01)

Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine
by: Ayaka Aso, et al.
Published: (2023-05-01)

One-pot and one-step automated radio-synthesis of [18F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experiment
by: Sadahiro Naka, et al.
Published: (2021-08-01)

FAP-Specific Signalling Is an Independent Diagnostic Approach in ACC and Not a Surrogate Marker of MRI Sequences
by: Dawn P. Liew, et al.
Published: (2022-08-01)

Impact of sunlight irradiation on CvFAP photodecarboxylation
by: Alexandre S. França, et al.
Published: (2023-04-01)

Signet cell rectal carcinoma with prostatic involvement detected by FAPI-04 PET-MRI fusion
by: K. Arun Prashanth, et al.
Published: (2023-12-01)

FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature
by: Priscilla Guglielmo, et al.
Published: (2024-02-01)

Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
by: Marko Magdi Abdou Sidrak, et al.
Published: (2023-02-01)

Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
by: Laura Gilardi, et al.
Published: (2022-02-01)